-
Mashup Score: 0Vepdegestrant Shows Potential in ESR1-Mutant ER+/HER2– Breast Cancer - 23 hour(s) ago
Debu Tripathy, MD, highlights the potential role and significance of vepdegestrant in pretreated ER-positive/HER2-negative breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
DCISionRT is a risk-assessment test for patients designed to predict RT benefit and develop their recurrence risk after surgery alone or with radiation.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 11Nomogram predicts survival and surgical benefits for patients with breast cancer with initial bone metastasis: A population‐based study - 1 day(s) ago
For patients with breast cancer with initial bone metastasis, clinicians can use this nomogram based on population studies to assess whether patients can benefit from surgery of the primary tumor les…
Categories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5
During a Case-Based Roundtable® event, Hope S. Rugo, MD, FASCO, moderated a discussion on treatment options for a patient whose breast cancer recurred several years after adjuvant therapy.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Supporting Patients With Breast Cancer: How Nurses Can Maximize Opportunities for Connection | Cancer Nursing Today - 2 day(s) ago
Panelists discuss how nurses can connect with patients who are receiving breast cancer treatment and how reducing treatment time benefits patients and clinics.
Source: cancernursingtoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0
Debu Tripathy, MD, highlights the potential role and significance of vepdegestrant in pretreated ER-positive/HER2-negative breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The latest KEYNOTE-756 data highlight the surgical outcomes of patients with high-risk early-stage estrogen receptor–positive breast cancer.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
In clinically node-positive breast cancer, clipping of lymph nodes may induce higher rates of sentinel lymph node surgery after neoadjuvant chemotherapy.
Source: www.cancernetwork.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Examining the Evolution of Treatment With CDK4/6 Inhibitors in Metastatic Breast Cancer - 4 day(s) ago
Anne Favret, MD discusses the FDA approval of capivasertib in combination with fulvestrant for HR-positive, HER2-negative breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0FDA Receives Type C Meeting Request for Pelareorep in HR+/HER2– Metastatic Breast Cancer - 4 day(s) ago
The FDA has received a type C meeting request from Oncolytics Biotech to discuss a registration-enabling trial for pelareorep in HR+/HER2– breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
Vepdegestrant Shows Potential in ESR1-Mutant ER+/HER2– Breast Cancer @DrDebuTripathy @mdandersonnews @sabcssanantonio #bcsm https://t.co/3UypkJBw1g